Joseph LaRosa
Vermögen: 26 Mio $ am 31.05.2026
Vermögen: 26 Mio $ am 31.05.2026
Joseph J.
LaRosa is currently Director at Biotechnology Innovation Organization, Secretary at Decibel Therapeutics, Inc. since 2023, and Secretary, Executive VP & General Counsel at Regeneron Pharmaceuticals, Inc. since 2019.
Former roles include Vice President-Global Compliance & Legal Affairs at Avon Products, Inc. in 2010, Vice President-Legal Affairs at Schering-Plough Corp.
from 1993 to 2009, and Secretary, Senior Vice President & General Counsel at Fougera Pharmaceuticals, Inc. Education includes graduate studies at New York University School of Law.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 14.04.2026 | 42’315 ( 0.04% ) | 26 Mio $ | 31.05.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| REGENERON PHARMACEUTICALS, INC. | General Counsel | 06.09.2011 |
| DECIBEL THERAPEUTICS, INC. | Unternehmenssekretär | 22.09.2023 |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology advocacy organization representing biotech companies, industry leaders and state biotech associations | Direktor/Vorstandsmitglied | - |
| Unternehmen | Position | Ende |
|---|---|---|
| AVON PRODUCTS, INC. | General Counsel | 01.01.2010 |
Schering-Plough Corp.
Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Manufactures and sells pharmaceutical & health care products | General Counsel | 01.01.2009 |
Fougera Pharmaceuticals, Inc.
Fougera Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures dermatology pharmaceuticals | General Counsel | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 7 |
|---|---|
Avon Products, Inc.
Avon Products, Inc. Household/Personal CareConsumer Non-Durables Manufactures and distributes beauty, skincare, fragrance & cosmetics products | Consumer Non-Durables |
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops, manufactures and commercializes medicines for diseases | Health Technology |
Schering-Plough Corp.
Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Manufactures and sells pharmaceutical & health care products | Health Technology |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology advocacy organization representing biotech companies, industry leaders and state biotech associations | Commercial Services |
Fougera Pharmaceuticals, Inc.
Fougera Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures dermatology pharmaceuticals | Health Technology |
New York University School of Law
New York University School of Law Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Decibel Therapeutics, Inc.
Decibel Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which develops medicines for hearing and balance disorders | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen